Photo of Yujin Hoshida

Yujin Hoshida

  • ASSISTANT PROFESSOR Medicine, Liver Diseases
Print ProfilePrint Profile


Hoshida laboratory

Hoshida lab employs multidisciplinary, translational approaches to chronic liver diseases including liver cirrhosis and cancer, with particular emphasis on genomics, biostatistics, bioinformatics, clinical diagnostics, and chemical biology, and is currently focusing on the following projects with NIH funding.

1. Molecular signature for clinical outcome prediction in liver cirrhosis and cancer.
2. Molecular classification of liver cancer to guide personalized treatment.
3. Nanotechnology-based drug delivery for treatment of liver cirrhosis and cancer.

View list of publications.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Hoshida during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.

  • Epizyme, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central


Hess Center for Science and Medicine; Tisch Cancer Institute
1470 Madison Ave, Box 1123
New York, NY 10029